Boston Scientific Receives FDA Approval for the Ranger(TM) Drug-Coated Balloon

Company provides physicians with first portfolio comprised of drug-eluting stent and drug-coated balloon for the treatment of patients with peripheral artery disease MARLBOROUGH, Mass., Nov. 2, 2020 -- (Healthcare Sales & Marketing Network) -- Boston S... Devices, Interventional, FDA, Product Launch Boston Scientific, Ranger, Drug-Coated Balloon, peripheral artery disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news